Merozoite Surface Protein Immunology in Plasmodium falciparum

Plasmodium falciparum merozoites, the invasive blood-stage form of the parasite, are densely coated with an array of surface proteins that mediate erythrocyte attachment, immune recognition and evasion. Among these, the polymorphic merozoite surface protein 1 (MSP1) complex is the most abundant and has long been a prime vaccine candidate. During invasion, MSP1 undergoes precise proteolytic processing that regulates exposure of binding domains and shields critical epitopes. Host immunity predominantly targets conformational epitopes within MSP1 and allied peripheral proteins, yet parasite antigenic variation, decoy motifs in low-complexity regions and mechanisms such as antigenic diversion can subvert neutralising antibody responses. A growing body of structural, immunological and clinical research is refining our understanding of epitope specificity, antibody isotype function and the balance between protective and interfering humoral responses, with important implications for next-generation blood-stage vaccines.

Research from Nature Portfolio

Recent studies have elucidated how human monoclonal antibodies with diverse neutralising capacities bind MSP1 and compete at overlapping sites. High-resolution structures reveal a strain-transcending neutralising epitope that is directly overlapped by high-affinity non-neutralising antibodies. In vitro assays demonstrate that these non-neutralising antibodies outcompete their neutralising counterparts at physiological concentrations, a process termed antigenic diversion, thereby permitting merozoite survival despite the presence of potentially protective antibodies. These insights define the structural and mechanistic basis of immune evasion by antibody interference and underscore the need to focus vaccine design on subdominant, conserved neutralising epitopes.

Merozoite Surface Protein Immunology in Plasmodium falciparum publication trend

The graph below shows the total number of articles in merozoite surface protein immunology in plasmodium falciparum across all publications each year (not limited to Nature Index journals).

Technical terms

Merozoite: The invasive blood-stage form of Plasmodium falciparum responsible for erythrocyte entry and clinical disease.

Merozoite Surface Protein 1 (MSP1): The most abundant GPI-anchored protein on the merozoite surface, essential for erythrocyte invasion and a key vaccine target.

Epitope: The specific region of an antigen recognised by an antibody or T-cell receptor.

Antigenic diversion: An immune evasion mechanism in which non-neutralising antibodies outcompete neutralising antibodies for binding to the same antigenic site.

Cytophilic antibody: An antibody isotype (e.g. IgG1, IgG3) that binds Fc receptors on phagocytes, promoting opsonisation and parasite clearance.

References

1. Regulated maturation of malaria merozoite surface protein‐1 is essential for parasite growth. Molecular Microbiology (2010).
2. Low-Complexity Repetitive Epitopes of Plasmodium falciparum Are Decoys for Humoural Immune Responses. Frontiers in Immunology (2020).
3. Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion. Nature Communications (2022).
4. Natural Plasmodium falciparum Infection Stimulates Human Antibodies to MSP1 Epitopes Identified in Mice Infection Models upon Non-Natural Modified Peptidomimetic Vaccination. Molecules (2023).
5. Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial. npj Vaccines (2020).
6. Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes*. Journal of Biological Chemistry (2016).